TY - JOUR
T1 - Approach to Mycosis Fungoides in children
T2 - Consensus-based recommendations
AU - Zvulunov, Alex
AU - Neale, Holly
AU - Stern, Jonah
AU - Santaguida, Pasqualina
AU - Stein, Amy Buros
AU - Koh, Mark
AU - Eichenfield, Lawrence F.
AU - Guitart, Joan
AU - Goebeler, Matthias
AU - Scarisbrick, Julia
AU - Willemze, Rein
AU - Coughlin, Carrie C.
AU - George, Renu
AU - Brazzelli, Valeria
AU - Marschalkó, Márta
AU - Belousova, Irena
AU - Querfeld, Christiane
AU - Bagot, Martine
AU - Szepietowski, Jacek C.
AU - Papadavid, Evangelina
AU - Quaglino, Pietro
AU - Hoeger, Peter
AU - Ortiz-Romero, Pablo L.
AU - Nikolaou, Vasiliki
AU - Dummer, Reinhard
AU - Aung, Phyu P.
AU - Lawley, Leslie
AU - Morel, Kimberly D.
AU - Ngan, Bo
AU - Wain, Mary
AU - Gameiro, Ana
AU - Lacy-Niebla, Rosa María
AU - Pope, Elena
N1 - Publisher Copyright:
© 2024 American Academy of Dermatology, Inc.
PY - 2024/12
Y1 - 2024/12
N2 - Background: Pediatric Mycosis fungoides (MF) management extrapolates from adult guidelines, despite differing clinical aspects. Recommendations are essential to address unique challenges in this distinct patient group. Objective: This project aims to derive consensus recommendations for pediatric MF management. Methods: Experts from pediatric dermatology, general dermatology, dermatopathology, and pediatric hematology-oncology (N = 83) were invited to contribute to consensus recommendations. The process involved 3 electronic Delphi rounds, concluding with a final consensus meeting using a modified Nominal Group Technique for unresolved items. Results: Consensus included more clinical severity measures than tumor-node-metastasis-blood staging: pruritus, functional or esthetic impairment (eg, palms, soles, genitalia), quality of life impact, and psychological aspects (eg, embarrassment, anxiety, depression), plus parental anxiety. Ten recommendations were made for managing early and advanced pediatric MF. Disagreement emerged in choosing therapies beyond stage I of the disease. Discussion: This multinational initiative aimed to standardize optimal pediatric MF management and successfully generated consensus recommendations. Additional work is needed for structured, prospective protocols in advanced-stage pediatric MF. Limitations: Lack of pediatric hematologists-oncologists and patients' representatives. Conclusion: Documentation of extended clinical severity and outcome measures is recommended. Addressing the need for structured protocols in advanced-stage pediatric MF and implementing systematic, prospective data collection is crucial.
AB - Background: Pediatric Mycosis fungoides (MF) management extrapolates from adult guidelines, despite differing clinical aspects. Recommendations are essential to address unique challenges in this distinct patient group. Objective: This project aims to derive consensus recommendations for pediatric MF management. Methods: Experts from pediatric dermatology, general dermatology, dermatopathology, and pediatric hematology-oncology (N = 83) were invited to contribute to consensus recommendations. The process involved 3 electronic Delphi rounds, concluding with a final consensus meeting using a modified Nominal Group Technique for unresolved items. Results: Consensus included more clinical severity measures than tumor-node-metastasis-blood staging: pruritus, functional or esthetic impairment (eg, palms, soles, genitalia), quality of life impact, and psychological aspects (eg, embarrassment, anxiety, depression), plus parental anxiety. Ten recommendations were made for managing early and advanced pediatric MF. Disagreement emerged in choosing therapies beyond stage I of the disease. Discussion: This multinational initiative aimed to standardize optimal pediatric MF management and successfully generated consensus recommendations. Additional work is needed for structured, prospective protocols in advanced-stage pediatric MF. Limitations: Lack of pediatric hematologists-oncologists and patients' representatives. Conclusion: Documentation of extended clinical severity and outcome measures is recommended. Addressing the need for structured protocols in advanced-stage pediatric MF and implementing systematic, prospective data collection is crucial.
KW - consensus
KW - mycosis fungoides
KW - pediatric
KW - severity and outcome measures
UR - http://www.scopus.com/inward/record.url?scp=85203801097&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85203801097&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2024.07.1501
DO - 10.1016/j.jaad.2024.07.1501
M3 - Article
C2 - 39181404
AN - SCOPUS:85203801097
SN - 0190-9622
VL - 91
SP - 1078
EP - 1085
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 6
ER -